Fresenius Medical Care AG (FRA:FME)

Market Cap	12.35B
Revenue (ttm)	19.34B
Net Income (ttm)	537.91M
Shares Out	n/a
EPS (ttm)	1.83
PE Ratio	22.96
Forward PE	n/a
Dividend	1.44 (3.46%)
Ex-Dividend Date	May 23, 2025

Volume	811,945
Average Volume	634,406
Open	43.84
Previous Close	44.13
Day's Range	41.44 - 43.95
52-Week Range	32.51 - 48.31
Beta	n/a
RSI	43.22
Earnings Date	May 6, 2025

About Fresenius Medical Care AG

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospital...

• Industry: Miscellaneous Health And Allied Services, Not Elsewhere Classified
• Founded: 1996
• Employees: 111,513
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: FME

Financial Performance

In 2024, Fresenius Medical Care AG's revenue was 19.34 billion, a decrease of -0.61% compared to the previous year's 19.45 billion. Earnings were 537.91 million, an increase of 7.80%.